TMEM125: A Potential Drug Target for Cancer (G128218)
TMEM125: A Potential Drug Target for Cancer
TMEM125 (Tumor Membrane Extrusion Model 125) is a protein that is expressed in various tissues of the body, including the skin, hair, and nails. It is also a well-established biomarker for cancer, and has been shown to be associated with the development and progression of several types of cancer.
TMEM125 is a transmembrane protein that is involved in the regulation of cell signaling pathways. It is a member of the tumor membraneextrusion (TMEM) family, which includes several other proteins that are involved in the process of cell signaling. TMEM125 is expressed in a variety of tissues, including the skin, hair, and nails, and has been shown to be involved in the development and progression of several types of cancer.
One of the key functions of TMEM125 is its role in cell signaling pathways. It is a negative regulator of the TGF-β pathway, which is a well-established pathway that is involved in the regulation of cell growth, differentiation, and survival. TGF-β is a cytoplasmic protein that is involved in the regulation of cell signaling pathways, and it is thought to play a role in the development and progression of cancer. TMEM125 is shown to interact with TGF-β and to inhibit its activity, which suggests that it may be a potential drug target for cancer.
In addition to its role in cell signaling pathways, TMEM125 is also involved in the regulation of cell adhesion. It is a member of the cadherin family of transmembrane proteins, which are involved in cell adhesion and the formation of tight junctions. TMEM125 is shown to be involved in the regulation of cadherin function, which suggests that it may be a potential biomarker for cancer.
TMEM125 is also involved in the regulation of cell migration. It is a member of the vimentin family of cytoskeletal proteins, which are involved in the regulation of cell migration. TMEM125 is shown to be involved in the regulation of vimentin function, which suggests that it may be a potential drug target for cancer.
In conclusion, TMEM125 is a transmembrane protein that is involved in the regulation of cell signaling pathways, cell adhesion, and cell migration. It is also a well-established biomarker for cancer and has been shown to be associated with the development and progression of several types of cancer. As such, TMEM125 may be a potential drug target for cancer. Further research is needed to determine the exact mechanisms of TMEM125's role in cancer and to develop effective treatments.
Protein Name: Transmembrane Protein 125
More Common Targets
TMEM126A | TMEM126B | TMEM127 | TMEM128 | TMEM129 | TMEM130 | TMEM131 | TMEM131L | TMEM132A | TMEM132B | TMEM132C | TMEM132D | TMEM132D-AS1 | TMEM132E | TMEM132E-DT | TMEM133 | TMEM134 | TMEM135 | TMEM138 | TMEM139 | TMEM139-AS1 | TMEM140 | TMEM141 | TMEM143 | TMEM144 | TMEM145 | TMEM147 | TMEM147-AS1 | TMEM14A | TMEM14B | TMEM14C | TMEM14DP | TMEM14EP | TMEM150A | TMEM150B | TMEM150C | TMEM151A | TMEM151B | TMEM154 | TMEM156 | TMEM158 | TMEM160 | TMEM161A | TMEM161B | TMEM161B-DT | TMEM161BP1 | TMEM163 | TMEM164 | TMEM165 | TMEM167A | TMEM167AP2 | TMEM167B | TMEM168 | TMEM169 | TMEM17 | TMEM170A | TMEM170B | TMEM171 | TMEM174 | TMEM175 | TMEM176A | TMEM176B | TMEM177 | TMEM178A | TMEM178B | TMEM179 | TMEM179B | TMEM18 | TMEM18-DT | TMEM181 | TMEM182 | TMEM183A | TMEM183BP | TMEM184A | TMEM184B | TMEM184C | TMEM185A | TMEM185B | TMEM186 | TMEM187 | TMEM19 | TMEM190 | TMEM191A | TMEM191B | TMEM191C | TMEM192 | TMEM196 | TMEM198 | TMEM198B | TMEM199 | TMEM200A | TMEM200B | TMEM200C | TMEM201 | TMEM202 | TMEM203 | TMEM204 | TMEM205 | TMEM207 | TMEM208